NGM Biopharmaceuticals In... (NGM)
NASDAQ: NGM
· Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM
NGM Biopharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.64 | -0.77 | -1.4 | -1.85 | -2.97 | -5.7 | -5.53 | -9.2 | -12.64 | -14.09 | -10.36 | -20.06 |
PEG Ratio | 0.11 | 0.03 | 0.09 | -0.06 | 0.11 | 3.31 | -0.13 | -0.54 | 2.34 | 0.61 | -0.31 | 2.01 |
PS Ratio | 431.08 | 152.06 | 150.08 | 148.91 | 22.58 | 133.30 | 122.54 | 56.80 | 65.72 | 87.60 | 90.64 | 102.45 |
PB Ratio | 0.48 | 0.52 | 1.11 | 1.51 | 1.58 | 3.69 | 3.48 | 3.82 | 4.10 | 4.60 | 4.08 | 5.53 |
P/FCF Ratio | -3.07 | -3.22 | -5.29 | -7.87 | -13.31 | -37.06 | -19.94 | -33.03 | -74.59 | -170.29 | -62.04 | -98.74 |
P/OCF Ratio | -3.1 | -3.26 | -5.31 | -8 | -13.5 | -37.47 | -20.26 | -33.29 | -75.13 | -173.86 | -65.22 | -99.45 |
OCF/S Ratio | -139.17 | -46.67 | -28.28 | -18.61 | -1.67 | -3.56 | -6.05 | -1.71 | -0.87 | -0.5 | -1.39 | -1.03 |
Debt / Equity Ratio | n/a | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | n/a | n/a | n/a |
Quick Ratio | 7.79 | 7.92 | 7.14 | 6.36 | 6.04 | 6.50 | 7.50 | 7.58 | 6.26 | 6.86 | 8.95 | 10.56 |
Current Ratio | 7.79 | 7.92 | 7.19 | 6.40 | 6.04 | 6.50 | 7.50 | 7.58 | 6.18 | 6.86 | 8.95 | 10.56 |
Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.06 | 0.02 | 0.02 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 |
Interest Coverage | -11.65 | n/a | n/a | n/a | -18.87 | -50.06 | -86.68 | -185.12 | n/a | n/a | n/a | n/a |
Return on Equity | -0.19 | -0.17 | -0.2 | -0.2 | -0.13 | -0.16 | -0.16 | -0.1 | -0.08 | -0.08 | -0.1 | -0.07 |
Return on Assets | -0.16 | -0.15 | -0.17 | -0.17 | -0.11 | -0.14 | -0.14 | -0.09 | -0.07 | -0.07 | -0.09 | -0.06 |
Return on Invested Capital | -0.2 | -0.18 | -0.21 | -0.21 | -0.14 | -0.16 | -0.16 | -0.1 | -0.08 | -0.08 | -0.1 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -2.14 | 0.14 | 0.21 | 0.50 | 0.94 | 0.86 | 0.83 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | -167.7 | -49.48 | -26.89 | -20.07 | -1.9 | -5.84 | -5.54 | -1.54 | -1.3 | -1.55 | -2.19 | -1.28 |
Pretax Profit Margin | -167.7 | -49.48 | -26.89 | -21.2 | -2 | -5.97 | -5.61 | -1.55 | -1.3 | -1.55 | -2.19 | -1.28 |
Operating Profit Margin | -179.78 | -53.32 | -28.51 | -22.34 | -2.11 | -6.11 | -5.68 | -1.56 | -1.3 | -1.56 | -2.18 | -1.29 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -176.64 | -52.4 | -28.12 | -22.34 | -2.11 | -6.03 | -5.51 | -1.49 | -1.3 | -1.48 | -2.09 | -1.22 |